Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston
3
×
boston blog main
boston top stories
life sciences
national blog main
national top stories
3
×
alnylam pharmaceuticals
harvard pilgrim health care
institute for clinical and economic review
new york blog main
rna interference
san francisco blog main
akcea therapeutics
alexion pharmaceuticals
alnylam pharmaceutials
amy schulman
andreas klein
anna greka
arrowhead pharmaceuticals
barry greene
biotech
boehringer ingelheim
car-t
caron jacobson
cigall kadoch
clinical trials
craig mello
dan ollendorf
deals
dicerna pharmaceuticals
drugs
eli lilly
european medicines agency
events
fda
foghorn therapeutics
gene therapy
goldfinch biopharma
hepatitis b
hereditary transthyretin amyloidosis
What
interference
3
×
rna
3
×
gene
medicines
rnai
abandoning
ago
alnylam
approves
aren’t
baggage
car
cells
companies
cuts
cutting
deal
development
dicerna
drug
edge
ema
employ
europe
experiments
fda
follows
free
gets
harmful
hits
hot
launch
long
make
market
medicine
method
mute
payers
Language
Current search:
interference
×
boston
×
" national top stories "
×
rna
×
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@xconomy.com
5 years ago
RNAi Hits Europe as EMA Follows FDA, Approves Alnylam Drug
@xconomy.com
6 years ago
CAR-T’s Launch, Payers vs. Gene Therapy & Photos From “What’s Hot”